• About
    • About Sutro
    • Patient Resources
    • Collaborations
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • The Way We Work
    • Join Our Team
    • Diversity, Equity, Inclusion and Belonging
      • DEIB Newsletter
    • Internships
    • Sutroites
    • Volunteer Opportunities
  • Contact Us
Navigation
  • About
    • About Sutro
    • Patient Resources
    • Partnerships
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Company Presentation
    • Stock
    • Financials
    • Governance
    • Contact IR
    • Email Alerts
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • Join Our Team
    • Diversity, Equity, Inclusion and Belonging
      • DEIB Newsletter
    • Internships
    • Sutroites
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • News Releases
    • Events & Audio Replays
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Functional Leadership Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analysts Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • News Releases
  • Events & Audio Replays
  • Email Alerts
Sep 26, 2018 6:58pm EDT

Sutro Biopharma Announces $85.0 Million Initial Public Offering

Sep 12, 2018 8:00am EDT

Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief

Aug 13, 2018 8:00am EDT

Sutro and The Leukemia & Lymphoma Society Partner on Lymphoma and Multiple Myeloma Treatment

Jul 26, 2018 10:45am EDT

Sutro Biopharma Announces $85.4 Million Series E Round

Jul 24, 2018 8:00am EDT

Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders

Apr 26, 2018 8:00am EDT

Sutro Initiates First Clinical Trial of CD74-Targeting ADC for Lymphoma & Multiple Myeloma Treatment; The First of a New Generation of Precisely Engineered ADCs

Apr 16, 2018 6:30am EDT

Sutro ADC Effectively Targets Folate Receptor Alpha in Ovarian Cancer Preclinical Research

Dec 12, 2017 8:00am EST

Sutro Antibody Effectively Targets CD74 in Lymphoma & Multiple Myeloma Preclinical Studies

Oct 11, 2017 8:00am EDT

Sutro Marks Two Drug Development Milestones

Aug 10, 2017 8:00am EDT

Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

  • Previous
  • 1…
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080
Phone: 650-881-6500
Fax: 650-553-9659

Google Map

Tweets by @sutrobio

Contact Us

General Inquires:
general@sutrobio.com
Business Inquires:
busdev@sutrobio.com
Investor Relations Inquires:
IR@sutrobio.com 
Careers:
jobs@sutrobio.com

© 2022 Sutro Biopharma, Inc. -- Privacy Policy
  • Follow
  • Follow
  • Follow